Copyright
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. May 18, 2015; 7(8): 1074-1085
Published online May 18, 2015. doi: 10.4254/wjh.v7.i8.1074
Published online May 18, 2015. doi: 10.4254/wjh.v7.i8.1074
Autoantibodies in chronic hepatitis C: A clinical perspective
Janaína Luz Narciso-Schiavon, Leonardo de Lucca Schiavon, Department of Internal Medicine, Gastroenterology Division, Federal University of Santa Catarina, Florianópolis, Santa Catarina 88040-900, Brazil
Author contributions: Both authors contributed to this manuscript.
Conflict-of-interest: None declared.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Janaína Luz Narciso-Schiavon, MD, PhD, Department of Internal Medicine, Gastroenterology Division, Federal University of Santa Catarina, R. Prof. Ma Flora Pausewang s/no, 3º andar, Trindade, Florianópolis, Santa Catarina 88040-900, Brazil. janaina.narciso@uol.com.br
Telephone: +55-48-37219149 Fax: +55-48-37219014
Received: September 26, 2014
Peer-review started: September 28, 2014
First decision: December 17, 2014
Revised: January 16, 2015
Accepted: February 4, 2015
Article in press: February 9, 2015
Published online: May 18, 2015
Processing time: 235 Days and 8 Hours
Peer-review started: September 28, 2014
First decision: December 17, 2014
Revised: January 16, 2015
Accepted: February 4, 2015
Article in press: February 9, 2015
Published online: May 18, 2015
Processing time: 235 Days and 8 Hours
Core Tip
Core tip: We review the prevalence of Non-organ-specific autoantibodies, thyroid autoantibodies, and gluten-related seromarkers and their significance in predicting autoimmune diseases in individuals with hepatitis C. Autoantibodies’ importance for treatment choice and possible complications due to their presence during interferon-based treatment are appraised.